Proniosomes as drug carriers
- PMID: 20067875
Proniosomes as drug carriers
Abstract
Approaches to stabilize niosomal drug delivery system without affecting its properties of merits have resulted in the development of the promising drug carrier, proniosomes. Proniosomes is dry formulation using suitable carrier coated with non ionic surfactants and can be converted into niosomes immediately before use by hydration. These proniosome-derived niosomes are as good as or even better than conventional niosomes. The focus of this review is to bring out different aspects related to proniosomes preparation, characterization, entrapment efficiency, in vitro drug release, applications and merits.
Similar articles
-
A review on novel vesicular drug delivery: proniosomes.Drug Deliv. 2014 Jun;21(4):243-9. doi: 10.3109/10717544.2013.841783. Epub 2013 Oct 16. Drug Deliv. 2014. PMID: 24128089 Review.
-
Proniosomes as a drug carrier for transdermal delivery of ketorolac.Eur J Pharm Biopharm. 2005 Apr;59(3):485-90. doi: 10.1016/j.ejpb.2004.09.006. Eur J Pharm Biopharm. 2005. PMID: 15760729
-
Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.Int J Pharm. 2008 Sep 1;361(1-2):104-11. doi: 10.1016/j.ijpharm.2008.05.031. Epub 2008 Jun 3. Int J Pharm. 2008. PMID: 18577437
-
Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.J Microencapsul. 2009 May;26(3):272-8. doi: 10.1080/02652040802305618. Epub 2008 Oct 20. J Microencapsul. 2009. PMID: 18720197
-
Technology overview and drug delivery application of proniosome.Pharm Dev Technol. 2017 May;22(3):302-311. doi: 10.3109/10837450.2015.1135344. Epub 2016 Jan 21. Pharm Dev Technol. 2017. PMID: 26794727 Review.
Cited by
-
Proniosomes Nanoparticle for the Treatment of Peripheral Arterial Disease.Pharm Nanotechnol. 2024;12(5):428-437. doi: 10.2174/2211738511666230912160729. Pharm Nanotechnol. 2024. PMID: 37702235 Review.
-
Percutaneous Delivery of Antihypertensive Agents: Advances and Challenges.AAPS PharmSciTech. 2020 Jan 6;21(2):56. doi: 10.1208/s12249-019-1583-9. AAPS PharmSciTech. 2020. PMID: 31909450 Review.
-
Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.Biomedica. 2022 Mar 1;42(1):67-84. doi: 10.7705/biomedica.5913. Biomedica. 2022. PMID: 35471171 Free PMC article.
-
Nano-platform Strategies of Herbal Components for the Management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations.Curr Drug Deliv. 2024;21(8):1082-1105. doi: 10.2174/1567201821666230825102748. Curr Drug Deliv. 2024. PMID: 37622715 Review.
-
Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.ISRN Pharm. 2012;2012:474830. doi: 10.5402/2012/474830. Epub 2012 Jul 19. ISRN Pharm. 2012. PMID: 22888455 Free PMC article.